This filing reports the ownership of securities by Jean I Liu, a director at Connect Biopharma Holdings Ltd. The report details holdings of stock options, which are derivative securities. Several stock options are listed with their respective exercise dates, expiration dates, and conversion/exercise prices. These optio...

This filing, a Form 3, reports initial beneficial ownership of securities for Karen J. Wilson, a director at Connect Biopharma Holdings Ltd. The filing details direct holdings of ordinary shares amounting to 10,000 shares. Additionally, it discloses various stock options to purchase ordinary shares, with exercise price...

This filing details Barry D. Quart's ownership of Connect Biopharma Holdings Ltd. securities. As of March 16, 2026, Quart directly owns 95,147 ordinary shares and indirectly owns an additional 128,887 ordinary shares through a joint account with his spouse. The filing also discloses several stock options granted to Qua...

This filing reports on derivative holdings for James A. Schoeneck, a director at Connect Biopharma Holdings Ltd. The report details two stock options: one with an exercise price of $2.38 and an expiration date of July 22, 2035, for 120,000 ordinary shares, subject to vesting over three years. The second stock option ha...

This filing details the ownership of securities by David Leslie Szekeres, President of Connect Biopharma Holdings Ltd. As of March 16, 2026, Mr. Szekeres directly holds 215,739 ordinary shares. The filing also reports on various employee stock options granted to him, with different vesting schedules and expiration date...

This SEC Form 3 filing reports the initial statement of beneficial ownership for Lisa Peraza, Senior Vice President of Finance at Connect Biopharma Holdings Ltd (CNTB). The filing discloses Peraza's ownership of 45,189 ordinary shares and multiple stock option grants. The options include: 400,000 shares at $1.15 expiri...

This filing details the ownership of securities by reporting owner Kleanthis Gabriel Xanthopoulos, who is a director at Connect Biopharma Holdings Ltd. The filing indicates direct ownership of 80,000 ordinary shares. Additionally, it outlines various stock options with different exercise prices and expiration dates, al...